Skip to main content

Achieve Life Sciences Inc(ACHV-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development

Globe Newswire - Tue Nov 9, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced third quarter 2021 financial results and provided an update on the cytisinicline clinical development program.


Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.